Nexstim Plc

Helsinki Stock Exchange NXTMH.HE

Nexstim Plc Price to Book Ratio (P/B) on January 14, 2025: 20.04

Nexstim Plc Price to Book Ratio (P/B) is 20.04 on January 14, 2025, a 200.81% change year over year. Price to book ratio compares the stock price to the book value per share; above 1 indicates market values company more than its book value.

Nexstim Plc 52-week high Price to Book Ratio (P/B) is 22.01 on January 07, 2025, which is 9.84% above the current Price to Book Ratio (P/B).
Nexstim Plc 52-week low Price to Book Ratio (P/B) is 5.37 on April 16, 2024, which is -73.21% below the current Price to Book Ratio (P/B).
Nexstim Plc average Price to Book Ratio (P/B) for the last 52 weeks is 9.09.

Key data

Date	Price to Book Ratio (P/B)	Dividend Yield	Free Cash Flow Yield	Price to Earnings Ratio (P/E)

Helsinki Stock Exchange: NXTMH.HE

Nexstim Plc

CEO	Mr. Mikko Karvinen
IPO Date	Nov. 14, 2014
Location	Finland
Headquarters	ElimAeenkatu 9 B
Employees	39
Sector	Health Care
Industries Pharmaceuticals Biotechnology

Description

Nexstim Plc, a medical technology company, engages in the development and marketing of non-invasive brain stimulation technologies in Finland, rest of Europe, North America, and internationally. The company's proprietary SmartFocus technology with 3D navigation is the navigated transcranial magnetic stimulation (TMS) approach that is used for therapeutic and diagnostic applications. It offers NBT system, a navigated brain therapy system for the treatment of major depression and chronic neuropathic pain; and NBS system, a navigated brain stimulation system for pre-surgical mapping of the speech and motor cortices of the brain. The company primarily sells its NBS systems to universities and teaching hospitals. Nexstim Plc was founded in 2000 and is headquartered in Helsinki, Finland.

Key trends

Past 5 years